Clinical data | |
---|---|
Other names |
|
ATC code |
|
Pharmacokinetic data | |
Metabolism | liver |
Excretion | kidneys |
Identifiers | |
IUPAC name
| |
CAS Number |
|
PubChem CID |
|
ChemSpider |
|
UNII |
|
KEGG |
|
ChEMBL |
|
CompTox Dashboard (EPA) |
|
Chemical and physical data | |
Formula | C14H15IN2O |
Molar mass | 354.191 g·mol−1 |
3D model (JSmol) |
|
SMILES
| |
InChI
|
Enisamium iodide is a derivative of isonicotinic acid. Based on its systematic chemical name of N-benzyl-1-methylpyridin-1-ium-4-carboxamide iodide, the shortened name carbabenzpiride is sometimes used. Enisamium iodide is a registered antiviral drug sold in Ukraine, Kazakhstan, Mongolia, Belarus, and other Eastern European countries under the trade names Amizon, Amizon Max, Amizonchik.[1]
In 2019, the World Health Organization assigned enisamium iodide ATC code – J05AX17 (Antivirals for systemic use of direct action) and included it in the ATC / DDD index.[2]